- Trials with a EudraCT protocol (4,394)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9,983)
Query did not match any clinical trials.
These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging : Frühwald MC, Rickert CH, O'Dorisio MS, Madsen M, Warmuth-Metz M, Khanna G, Paulus W, Kühl J, Jürgens H, Schneider P, Müller HL; Clin Cancer Res. 2004 May 1;10(9):2997-3006 |
Active substance: (111In) INDIUM CHLORIDE/PENTETREOTIDE |
Study summary document link (including results): |
View full study record |
Document reference: 21232 |
Study title: Patients with seasonal allergic rhinitis, conjunctivitis and possobly asthma symptoms so far only statistical analysis, Publication sheduled. Age of patients: 5 - 79 Years |
Active substance: 158 Rye |
Study summary document link (including results): |
View full study record |
Document reference: 39753 |
Study title: ACARBOSE (BAY G 5421) IN INSULIN-DEPENDENT DIABETES - THE EFFECT ON THE DAILY BLOOD-GLUCOSE PROFILE AND ON THE INSULINCONSUMPTION BY AN ARTIFICIAL PANCREAS (STUDY 0160)(PH-9873) |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0160_study_synopsis.pdf |
View full study record |
Document reference: 46154 |
Study title: Assessment of efficacy and tolerability of Acarbose in children under 16 years |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_9981_study_synopsis.pdf |
View full study record |
Document reference: 46160 |
Study title: Clinical Study on the Efficacy and Tolerability of Acarbose (BAY g 5421) Compared with Placeboin Diabetic Children on Conventional Insulin Treatment, in Particular with Observation of the Glycemic Control Index ( PH-24820 ) |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0665_study_synopsis.pdf |
View full study record |
Document reference: 46158 |
Study title: Clinical Study to Investigate the Efficacy and Tolerability of Acarbose (BAY g 5421) Versus Placebo in Diabetic Children (PH 23433) |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0634_study_synopsis.pdf |
View full study record |
Document reference: 46155 |
Study title: Double-Blind, Cross-Over Clinical Study at a Single Centre to Compare Acarbose (BAY g 5421) with Placebo in Respect of Efficacy and Tolerability in Patients with Cystic Fibrosis and Pathological Glucose Tolerance (Pilot Study)(PH-26068) |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0696_study_synopsis.pdf |
View full study record |
Document reference: 46159 |
Study title: NON RANDOMISED FOLLW-UP STUDY WITH ACARBOSE-TREATMENT AND PRE- AND AFTER-TREATMENT WITH PLACEBO IN DIABETIC CHILDREN (TYPE I) STUDY 0428 (PH 14352) |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0428_study_synopsis.pdf |
View full study record |
Document reference: 46156 |
Study title: The effect of acarbose (Bay G 5421) on the insulin consumption of children treated with insulin. |
Active substance: ACARBOSE |
Study summary document link (including results): Bayer Pharma_Acarbose_0221_study_synopsis.pdf |
View full study record |
Document reference: 46157 |
Study title: Blockers and hypoglycaemia (assesment of cadioselective and intrinsic sympathometic properties in relation to severity of hypoglycaemia - No author - 1984 (Current Therapeutic Research 36, n° 2, p. 361-373) ; - Publication in Documentation clinique du dossier d'AMM du 30/10/1987 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46182 |
Study title: Clinical and echocardiographic (echo) long-term follow-up of children with severe hypertension (HT) - Loirat C. et al. - No date (Hopital Bretonneau, INSERM U 120, Paris) ; - Publication in Documentation clinique du dossier d'AMM du 30/10/1987 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46183 |
Study title: Clinical pharmacology and therapeutic utilization of anti-hypertensive agents in children - Mirkin B.L., Sinaiko - 1977 In : (New M.I., Levine L.S. Juvenile hypertension, pp. 195-218. New-York, Raven Press.) - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46184 |
Study title: Experience with acebutolol in the treatment of juvenile hypertension - J. Liška et al.- 2005 (VOX PEDIATRIAE – January 2005 – No.1 – Volume 5) |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46185 |
Study title: Expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46186 |
Study title: La tension artérielle chez l'enfant et l'adolescent. Valeurs rapportées à l'âge et à la taille chez 17.067 sujets - André J.L., Deschamps J.P., Gueguen R. - 1980 (Arch. Franç., 37, 1477) ; - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46187 |
Study title: Nouveaux regards sur l'hypertension artérielle de l'enfant - Broyer M., André J.L. - 1980 (Arch. Franç. Pediatr., 37, pp. 429-432) ; - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46188 |
Study title: Propanolol as an antihypertensive agent in children - Griswold W.R., Moneal R., Mendoza S.A. et al. - 1978 (Arch. Dis. Child. 537. pp 594-596) - Publication in Expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46189 |
Study title: Relazione sulla sperimentazione clinica del Sectral Roger Bellon nelle aritmie - Centro A De Gasperis Milano - Prof F Rovelli - 03 Jan 1978 |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46190 |
Study title: Report of the task force on blood pressure control in children - Blumenthal S., Epps R.P., Heavenrich R., Laver R.M., Lieberman E. and al. - 1977 (Pediatrics, suppl., 59, 797) ; - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46191 |
Study title: Résultats du traitement de l'hypertension artérielle essentielle après administration prolongée (24 mois) d'acebutolol - Fillastre J.P., Letac B., Wolf L.M.- 1975 (Nouv. Presse Med. 4, pp. 3282-3286) ; - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200 mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
Active substance: ACEBUTOLOL |
Study summary document link (including results): |
View full study record |
Document reference: 46192 |